F. Hepp
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
Papers in
- Oncology 4
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Stephan Braun (11 shared papers)Klaus Pantel (9 shared papers)Wolfgang Janni (7 shared papers)Christina Kentenich (8 shared papers)Harald Sommer (7 shared papers)Gert Riethmüller (2 shared papers)T. Dimpfl (2 shared papers)Peter E. Müller (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (3 papers)European Journal of Cancer (2 papers)International Journal of Cancer (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
F. Hepp
14 papers receiving 1.6k citations
F. Hepp's Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 634
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 237
- Pathology and Forensic Medicine 119
- Hematology 61
Countries citing papers authored by F. Hepp
This map shows the geographic impact of F. Hepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Hepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Hepp more than expected).
Fields of papers citing papers by F. Hepp
This network shows the impact of papers produced by F. Hepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Hepp. The network helps show where F. Hepp may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Hepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer Hit paper breakdown → | 2000 | 753 |
| 2 | 2000 | 321 | |
| 3 | 2001 | 118 | |
| 4 | Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. | 1999 | 110 |
| 5 | 2001 | 98 | |
| 6 | 1999 | 94 | |
| 7 | 2001 | 64 | |
| 8 | 2001 | 64 | |
| 9 | 2000 | 58 | |
| 10 | 2003 | 22 | |
| 11 | Potential clinical relevance of micrometastatic breast cancer | 1998 | 1 |
| 12 | 1999 | 1 | |
| 13 | 1999 | 1 | |
| 14 | [Incidence and prognostic significance of disseminated tumor cells in patients with cervical cancer]. | 2002 | 1 |
About F. Hepp
F. Hepp is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), HER2/EGFR in Cancer Research (2 papers), Breast Cancer Treatment Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper), Immunotherapy and Immune Responses (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Cancer Research (634 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (237 citations), Pathology and Forensic Medicine (119 citations) and Hematology (61 citations). F. Hepp has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Stephan Braun, Klaus Pantel, Wolfgang Janni, Christina Kentenich, Harald Sommer, Gert Riethmüller, T. Dimpfl, Peter E. Müller, Günter Schlimok and F Willgeroth. Their work appears in journals such as Journal of Clinical Oncology, Cancer, European Journal of Cancer, International Journal of Cancer and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.